'Amyloidosis' diaporamas de présentation

PATHOPHYSIOLOGY OF ORAL CAVITY

2.72k views • 53 slides

General Pathology

560 views • 34 slides

General Pathology

344 views • 34 slides

Immunopathology

Immunopathology. Ahmad Abu Alsamen MD. Auto immuno diseases. Organ-Specific Systemic Hashimoto thyroiditis Systemic lupus erythematosus Autoimmune hemolytic anemia Rheumatoid arthritis Autoimmune atrophic gastritis

420 views • 27 slides

Cardiac Amyloidosis

1.1k views • 26 slides

Case presentation

Case presentation. Dr. Sahban Almalah Presenet by Dr. Hasanin M.Ali. ???? ???? ????? 52 years old married Infertile D.O.A. 17-2-2011 D.O.D. 03-3-2011.

356 views • 23 slides

Case report

Case report. Zuzana Humlova Department of Pathophysiology. History. 1970 - hypertension related to fibromuscular dysplasia of the right renal artery; saphenous-vein bypass graft had failed, resulting in a poorly functioning right kidney 1976 - developed angina pectoris

900 views • 23 slides

Case report

Case report. Zuzana Humlova Department of Pathophysiology. History. 1970 - hypertension related to fibromuscular dysplasia of the right renal artery; saphenous-vein bypass graft had failed, resulting in a poorly functioning right kidney 1976 - developed angina pectoris

239 views • 23 slides

DOCTORS of Amyloidosis

DOCTORS of Amyloidosis Amyloidosis is a rare disease that occurs when a substance called amyloid builds up in your organs.

185 views • 18 slides

Amyloidosis

Pathology of Amyloidosis

780 views • 11 slides

Global Amyloidosis Treatment Market Size, Growth | Industry Report, 2025

Amyloidosis Treatment Market Size, Share & Trends Analysis Report By Treatment (Stem Cell Transplant, Chemotherapy, Supportive Care, Surgery, Targeted Therapy), By Country, And Segment Forecasts, 2018 - 2025

72 views • 7 slides

Amyloidosis Treatment Market Size, Share, Growth and Forecast to 2025 | Grand View Research

The global Amyloidosis Treatment Market size is expected to reach USD 6.7 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.2% CAGR during the forecast period. Several factors such as increased adoption of novel targeted therapies and transplantations, emergence of biologics, and rising geriatric population are driving the market.

75 views • 7 slides